Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
aragon1959's Profile
Displaying 51-100 of 125 result(s).
IPIX Innovation Pharmaceuticals Inc
05/20/2019 6:05:05 PM
I absolutely agree with you Bandg C (1)
IPIX Innovation Pharmaceuticals Inc
05/20/2019 5:16:13 PM
Pete I will likely disappoint you e
IPIX Innovation Pharmaceuticals Inc
05/19/2019 5:00:55 PM
very well said Kelt Term sheet is i (4)
IPIX Innovation Pharmaceuticals Inc
05/17/2019 6:03:12 PM
Bravo Pete Well said Bravo my Frien
IPIX Innovation Pharmaceuticals Inc
05/17/2019 1:07:09 PM
many thanks for clarifying it ,Some
IPIX Innovation Pharmaceuticals Inc
05/17/2019 11:58:57 AM
questions to all my colleagues on t
IPIX Innovation Pharmaceuticals Inc
05/16/2019 10:31:37 AM
Great news !!!! Congrats to all fai (6)
IPIX Innovation Pharmaceuticals Inc
05/12/2019 4:37:28 PM
Kepivance (palifermin) made by Amge (2)
IPIX Innovation Pharmaceuticals Inc
05/09/2019 5:24:07 PM
I can't stop thinking that before " (1)
IPIX Innovation Pharmaceuticals Inc
05/01/2019 4:45:46 PM
You are absolutely right Pete SOM i (7)
IPIX Innovation Pharmaceuticals Inc
04/26/2019 2:31:22 PM
you are right Drano B-OM is inexpen (3)
IPIX Innovation Pharmaceuticals Inc
04/26/2019 12:00:32 PM
I agree with you Topsin and respect (1)
IPIX Innovation Pharmaceuticals Inc
04/25/2019 11:30:24 AM
excellent comments Pete. If I may a (2)
IPIX Innovation Pharmaceuticals Inc
04/24/2019 4:57:33 AM
Slow and very selective "dosing" of (7)
IPIX Innovation Pharmaceuticals Inc
03/16/2019 5:04:02 PM
you are absolutely right
IPIX Innovation Pharmaceuticals Inc
03/16/2019 4:03:35 PM
You are right Smokenhot Problem wit
IPIX Innovation Pharmaceuticals Inc
03/16/2019 3:35:10 PM
I guess I am repeating myself but c (4)
IPIX Innovation Pharmaceuticals Inc
03/15/2019 3:43:58 PM
you are absolutely correct Drano In (2)
IPIX Innovation Pharmaceuticals Inc
03/15/2019 3:23:30 PM
65K cases of H&N cancer will be dia (6)
IPIX Innovation Pharmaceuticals Inc
03/07/2019 3:55:43 PM
I have it aragon
IPIX Innovation Pharmaceuticals Inc
03/03/2019 11:07:15 AM
Thanks Commando911 I appreciate you (2)
IPIX Innovation Pharmaceuticals Inc
03/02/2019 12:32:08 PM
I have the question to all faithful
IPIX Innovation Pharmaceuticals Inc
02/26/2019 4:43:34 PM
JnJ would be ideal suitor as the bi
IPIX Innovation Pharmaceuticals Inc
02/25/2019 5:37:32 PM
adding to my previous post...will P
IPIX Innovation Pharmaceuticals Inc
02/25/2019 3:11:25 PM
I am so interested, how PIII trial (2)
IPIX Innovation Pharmaceuticals Inc
02/06/2019 12:33:22 PM
good luck Kelt!!!!!! We all love... (2)
IPIX Innovation Pharmaceuticals Inc
02/01/2019 7:48:17 AM
I agree with you BooDog and wonder (5)
IPIX Innovation Pharmaceuticals Inc
01/27/2019 12:57:58 PM
good thinking Pete . I am not GI ex (2)
IPIX Innovation Pharmaceuticals Inc
12/17/2018 3:09:06 PM
good point Drano For this reasons m (1)
IPIX Innovation Pharmaceuticals Inc
12/17/2018 8:25:12 AM
you are right again agree with you
IPIX Innovation Pharmaceuticals Inc
12/17/2018 8:04:59 AM
you are right Drano They must have
IPIX Innovation Pharmaceuticals Inc
12/17/2018 7:53:30 AM
Head and Neck cancer is 6th most co (1)
IPIX Innovation Pharmaceuticals Inc
11/27/2018 2:26:14 PM
thx Kelt and Bravo(!!!!) Pete for s (3)
IPIX Innovation Pharmaceuticals Inc
11/26/2018 11:37:36 AM
and from purely practical point of (9)
IPIX Innovation Pharmaceuticals Inc
11/26/2018 11:16:13 AM
thx that's right...no standard of t (5)
IPIX Innovation Pharmaceuticals Inc
11/26/2018 11:03:30 AM
thx S Do you know what is control a
IPIX Innovation Pharmaceuticals Inc
11/22/2018 5:43:14 PM
I agree with your interpretation Pe (4)
IPIX Innovation Pharmaceuticals Inc
11/18/2018 2:27:17 PM
excellent post, Pete thank you for
IPIX Innovation Pharmaceuticals Inc
11/17/2018 1:23:16 PM
agree 100% with you Chem I still be (4)
IPIX Innovation Pharmaceuticals Inc
11/17/2018 10:53:20 AM
I still expect BTD for B-OM first b (2)
IPIX Innovation Pharmaceuticals Inc
11/11/2018 8:29:43 AM
Pete Just to add to the previous re (1)
IPIX Innovation Pharmaceuticals Inc
11/11/2018 8:02:40 AM
not necessary Pete 'late breaking p (3)
IPIX Innovation Pharmaceuticals Inc
11/10/2018 9:52:15 AM
Brilliant post Mo Thx
IPIX Innovation Pharmaceuticals Inc
11/09/2018 12:22:52 PM
Dear IPIX club members I cant stop (5)
IPIX Innovation Pharmaceuticals Inc
11/09/2018 7:15:36 AM
Pete I always respect your opinions (2)
IPIX Innovation Pharmaceuticals Inc
11/06/2018 4:32:44 PM
phase IV clinical trial listen (fay
IPIX Innovation Pharmaceuticals Inc
11/03/2018 4:09:59 PM
I think BTD will come first and wou (6)
IPIX Innovation Pharmaceuticals Inc
11/03/2018 2:36:03 PM
27 years in medical oncology 20% of (10)
IPIX Innovation Pharmaceuticals Inc
11/03/2018 10:06:32 AM
I agree with you TPB No need for PI (7)
IPIX Innovation Pharmaceuticals Inc
10/28/2018 2:39:13 PM
In very recent 10K there is paragra (1)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Joe Rogan Challenges the Ailments of the Insurance Industry
  • Tesla's Robotaxi Dreams Ignite Stock Prices Amid Hype
  • Arbor Realty Trust to Host Earnings Call for Q2 2025 Results
  • J.M. Smucker's Financial Woes and Investor Concerns Unveiled
  • Portage Biotech's Fiscal Year 2025 Financial Insights Revealed
  • Investors in Replimune Group, Inc. Can Join Class Action Today
  • Opportunity for Luminar Technologies, Inc. Investors to Join Lawsuit
  • Treatment.com AI Secures C$3 Million in Innovative Financing
  • Investors In Reckitt Benckiser Group PLC May Pursue Class Action
  • Silvercrest Asset Management's Upcoming Earnings Call Details
  • Exploring BlackRock's Stock Growth Over a Decade: Insights
  • NurExone Biologic Approved as Finalist for Prestigious Award
  • Silvercrest Asset Management Prepares for Next Earnings Call
  • Celcuity’s Upcoming Conference Call on PIK3CA Trial Results
  • Iradimed Corporation Schedules Q2 2025 Financial Update Call
  • Recognify Life Sciences Shares Phase 2b Trial Findings for Inidascamine
  • Celcuity Prepares for Groundbreaking VIKTORIA-1 Results Reveal
  • IRADIMED CORPORATION Set to Share Q2 2025 Financial Insights
  • Understanding the P/E Ratio for Otis Worldwide's Stock
  • Analyzing FedEx's Recent Options Movements and Trends
  • Understanding Options Trends of Lowe's Companies for Investors
  • Exploring Options Trends and Insights for Palo Alto Networks
  • Economic Shifts and Corporate Performance Influence Markets
  • TSA Invites Innovations for Improved Airport Security Measures
  • Pacific West Bancorp Financial Performance Highlights
  • Pacific West Bancorp Reports Noteworthy Q2 Financial Achievements
  • Elemental: Reforged - The Return to Fantasy Strategy Gaming
  • ASI Show Chicago 2025 Welcomes Thousands of Promotional Experts
  • Flagstar Financial Announces Latest Dividend Payouts for Investors
  • Velo3D, Inc. Implements Strategic Reverse Stock Split Plan
  • Peoples Financial Services Corp. Announces Q3 2025 Dividend Plans
  • Legal Analysis: Investigating Barnes & Noble Education, Inc.
  • Impact of Recent Executive Order on Private Prison Stocks
  • Analyzing the Surge in Ford Motor's Short Interest Figures
  • Understanding Investor Sentiment Towards Valvoline's Future
  • Investor Sentiment and Trends Surrounding S&P Global Stocks
  • Exploring Opportunities for Dow Inc. Amid Market Dynamics
  • ARK Innovation ETF Thrives Amidst Changing Market Dynamics
  • Jones Walker Expands Tax Practice with New Partner in Minnesota
  • Significant Conference on Austin Tice's Ongoing Case
  • Formula GT: Revolutionizing Motorsport with Hypercar Innovations
  • Transforming Payments: MicroBitcoin (MBC) Now on Coinstore
  • Hubbell Incorporated Declares Robust Dividend for Investors
  • VCI Global Unveils SecureGPU™ - Innovative AI Compute Solution
  • Boulevard Kitchen & Oyster Bar Invites You to Seafood Delight
  • Investors Urged to Act on Neogen Corp Class Action Deadline
  • Update on Investor Class Action for RxSight, Inc. Stockholders
  • Legal Proceedings for Capricor Therapeutics Investors Unveiled
  • Innovative ELIXIR MD™ Device Launches in Mexico for Aesthetic Solutions
  • JD Martin Welcomes Adam Hayes as New Regional VP
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site